Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein

Michael B Battles1, Vicente Más2, Eduardo Olmedillas2

  • 1Department of Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth, Hanover, NH, 03755, USA.

Nature Communications
|November 17, 2017
PubMed

Insights

Researchers stabilized the human metapneumovirus (hMPV) F glycoprotein in its pre-fusion form, revealing its structure. This breakthrough aids in developing effective hMPV vaccines by understanding viral fusion mechanisms.

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • Human metapneumovirus (hMPV) causes significant respiratory illness in children.
  • The hMPV F glycoprotein is crucial for viral entry and a key target for neutralizing antibodies.
  • Previous studies were limited by the inability to obtain the F glycoprotein in its pre-fusion conformation.

Purpose of the Study:

  • To engineer and determine the crystal structure of a pre-fusion-stabilized hMPV F ectodomain.
  • To elucidate the molecular mechanisms of hMPV fusion and antibody interactions.

Main Methods:

  • Engineering a stabilized hMPV F ectodomain.
  • X-ray crystallography to determine the structure at 2.6 Å resolution.
  • Immunological studies including immunoglobulin depletion and mouse immunizations.

Main Results:

  • The crystal structure of the pre-fusion hMPV F ectodomain was determined.
  • Identified molecular determinants of strain-dependent, acid-induced fusion.
  • Revealed insights into the conformational changes from pre- to post-fusion states.
  • A dense glycan shield at the apex of pre-fusion hMPV F was observed, potentially hindering antibody recognition.

Conclusions:

  • The structural insights provide a foundation for understanding hMPV entry mechanisms.
  • The dense glycan shield differs from related viruses like hRSV, impacting vaccine design.
  • These findings are critical for the rational development of novel hMPV vaccine candidates.